Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells

Saved in:
Bibliographic Details
Published inCell death and differentiation Vol. 27; no. 8; pp. 2531 - 2533
Main Authors Thijssen, Rachel, Alvarez-Diaz, Silvia, Grace, Clea, Gao, Ming-yuan, Segal, David H., Xu, Zhen, Strasser, Andreas, Huang, David C. S.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.08.2020
Nature Publishing Group
Subjects
13/1
13/2
13/31
631/67/68
631/80
64/60
Apoptosis
Biochemistry
Biomedical and Life Sciences
Cell Biology
Cell Cycle Analysis
Comment
Life Sciences
Lymphoma
Myc protein
Stem Cells
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1350-9047
1476-5403
DOI:10.1038/s41418-020-0576-2